Department of Pediatric Cardiology, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.
Division of Pediatric Cardiology, Northwestern Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Curr Cardiol Rep. 2023 Mar;25(3):157-170. doi: 10.1007/s11886-023-01839-0. Epub 2023 Feb 7.
While there have now been a variety of large reviews on adult pericarditis, this detailed review specifically focuses on the epidemiology, clinical presentation, diagnosis, and management of pediatric pericarditis. We have tried to highlight most pediatric studies conducted on this topic, with special inclusion of important adult studies that have shaped our understanding of and management for acute and recurrent pericarditis.
We find that the etiology of pediatric pericarditis differs from adult patients with pericarditis and has evolved over the years. Also, with the current COVID-19 pandemic, it is important for pediatric clinicians to be aware of pericardial involvement both due to the infection and from vaccination. Oftentimes, pericarditis maybe the only cardiac involvement in children with COVID-19, and so caregivers should maintain a high index of suspicion when they encounter children with pericarditis. Large-scale contemporary epidemiological data regarding incidence and prevalence of both acute and recurrent pericarditis is lacking in pediatrics, and future studies should focus on highlighting this important research gap. Most of the current management strategies for pediatric pericarditis are from experiences gathered from adult data. Pediatric multicenter trials are warranted to understand the best management strategy for those with acute and recurrent pericarditis.
A 6-year-old child with a past history of pericarditis almost 2 months ago comes in with a 2-day history of chest pain and fever. Per mother, he stopped his steroids about 2 weeks ago, and for the last 2 days has had a temperature of 102F and has been complaining of sharp mid-sternal chest pain that gets worse when he lies down and is relieved when he sits up and leans forward. On examination, he is tachycardic (heart rate 160 bpm), with normal blood pressure for age. He appears to be in pain (5/10), and on auscultation has a pericardial friction rub. His lab studies are notable for elevated white blood cell count and inflammatory markers (CRP and ESR). His electrocardiogram reveals sinus tachycardia and diffuse ST-elevation in all precordial leads. His echocardiogram demonstrates normal biventricular function and a trace pericardial effusion. His cardiac MRI confirms recurrent pericarditis. He is started on indomethacin and colchicine. He has complete resolution of his symptoms by day 3 of admission and is discharged with close follow-up.
虽然现在已经有很多关于成人心包炎的大型综述,但本篇详细的综述专门关注儿科心包炎的流行病学、临床表现、诊断和治疗。我们试图突出关于这个主题的大多数儿科研究,并特别纳入对急性和复发性心包炎的理解和治疗有重要影响的重要成人研究。
我们发现儿科心包炎的病因与成人心包炎患者不同,并且多年来一直在演变。此外,由于目前的 COVID-19 大流行,儿科临床医生意识到感染和疫苗接种均可导致心包受累非常重要。心包炎在感染 COVID-19 的儿童中可能是唯一的心脏受累表现,因此护理人员在遇到心包炎儿童时应保持高度怀疑。关于急性和复发性心包炎的发病率和患病率,儿科缺乏大规模的当代流行病学数据,未来的研究应重点关注这一重要的研究空白。儿科心包炎的大多数当前治疗策略都是从成人数据中获得的经验。需要进行儿科多中心试验,以了解急性和复发性心包炎的最佳治疗策略。
一名 6 岁儿童,2 个月前曾有心包炎病史,因胸痛和发热 2 天来诊。据母亲描述,他大约 2 周前停用了类固醇,近 2 天来体温为 102°F,并一直抱怨胸骨中部锐痛,躺下时加重,坐起并前倾时缓解。体格检查时,他心动过速(心率 160 bpm),血压与年龄相符。他看起来很痛苦(5/10),听诊有心包摩擦音。实验室研究显示白细胞计数和炎症标志物(CRP 和 ESR)升高。心电图显示窦性心动过速和所有前胸部导联弥漫性 ST 段抬高。超声心动图显示双心室功能正常,微量心包积液。心脏 MRI 证实为复发性心包炎。他开始服用吲哚美辛和秋水仙碱。入院第 3 天,他的症状完全缓解,随后出院并密切随访。